Thursday, November 27, 2025

Continued Pandemic Uncertainty Causes Bank of America to Defer $7.7 Billion in Commercial Loans

In response to a struggling economy amid the coronavirus pandemic, the Bank of America has decided to defer a total of $7.7 billion in loans for its commercial clients.

As of July 23, nearly 2% of the bank’s commercial clients have had their loans modified in some way, such as payment deferrals for durations up to 90 days or waivers on loan covenants. In the meantime, Bank of America’s consumer and small-business division had to defer a total of $28.5 billion in loans, with over of 1.4 million consumers requesting a delay on their credit card payments. Of those that were granted deferrals, approximately 61% have so far made some form of payment, while another 33% have been making timely payments each month.

The Bank of America anticipates the current economic uncertainty to continue for the time being, as coronavirus cases continue to mount and initial job claims fail to show signs of a significant improvement. As a result, the negative macroeconomic environment will most likely contribute to a deterioration of the bank’s businesses.

Information for this briefing was found via Bloomberg. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

IAMGOLD Q3 Earnings: Market Responds With MASSIVE Price Lift

G Mining Q3 Earnings: Costs Down, Production Up

Endeavour Silver Q3 Earnings: On The Upswing

Recommended

Silver47 Hits 606 g/t Over 9.7 Metres Silver Equivalent In Final Assays From 2025 Drill Program At Red Mountain

Altamira Gold Encounters Second Porphyry Body, Hitting 3.5 g/t Gold Over 8.0 Metres

Related News

Record Number of Americans Quitting Their Jobs as Fears Over Coronavirus Infections Mount

As the US Bureau of Labour Statistics released its latest Job Openings and Labour turnover...

Tuesday, August 11, 2020, 10:15:31 AM

Revive Therapeutics Granted FDA Approval For Phase 3 Clinical Trial For Bucillamine In COVID-19 Treatment

It’s a big day for Revive Therapeutics (CSE: RVV) (OTC: RVVTF). The company announced this...

Friday, July 31, 2020, 09:16:29 AM

US Manufacturing Orders Drop by Record Amount Amid Coronavirus Pandemic

The coronavirus has caused significant disruptions across the US, shattering vital supply chains and reducing...

Tuesday, May 5, 2020, 06:03:00 PM

Goldman Sachs Projects Strong US Economy In 2021, But Notes Significant Obstacles Ahead

As the US continues to battle its second, significantly more severe wave of the coronavirus...

Friday, November 13, 2020, 12:06:38 PM

Steven Mnuchin: Those Receiving $2 Million Or More Under PPP To Be Audited

As part of the CARES Act, the US federal government unveiled the Paycheck Protection Program...

Wednesday, April 29, 2020, 02:17:00 PM